Levitra (vardenafil HCl)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Vardenafil, a selective phosphodiesterase (PDE) type 5 inhibitor, is a vasodilating agent.
Vardenafil is a selective inhibitor of phosphodiesterases (PDEs), with the greatest selectivity for PDE type 5, the principal isoenzyme of PDE involved in the metabolism of cyclic guanosine monophosphate (cGMP) to GMP in the corpora cavernosa of the penis.
During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpora cavernosa. Nitric oxide activates the enzyme guanylate cyclase, which stimulates the synthesis of cGMP. cGMP produces smooth muscle relaxation and increased blood flow into the corpora cavernosa. By selectively inhibiting PDE type 5, vardenafil increases cGMP concentrations in the corpora cavernosa of the penis, resulting in nitric oxide-stimulated vascular relaxation.
Vardenafil has no effect on erectile function in the absence of sexual stimulation.
Vardenafil produces a modest reduction in the maximum supine systolic/diastolic blood pressure (average of about 7/8 mm Hg) in patients with erectile dysfunction, accompanied by a small mean maximum heart rate increase of about 4 beats/minute. These effects are potentiated by concurrent use of organic nitrates, and such concurrent use is contraindicated.
USES: Vardenafil is used to treat male sexual function problems (impotence or erectile dysfunction-ED). In combination with sexual stimulation, vardenafil works by increasing blood flow to the penis to help a man get and keep an erection. This drug does not protect against sexually transmitted diseases (such as HIV, hepatitis B, gonorrhea, syphilis).
Using an effective barrier method (latex or polyurethane condom/dental dams) during sexual activity will help to decrease your risk of infection.
Generic name: vardenafil HCl
Pronunciation: (var-DEN-a-fil)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Levitra
Indications
The following indications are listed for Levitra:
- Erectile Dysfunction
Also known as: Impotency.
Dosing
Dosage of vardenafil hydrochloride is expressed in terms of vardenafil.
Patients should be advised to contact their clinician for dose modification if they are not satisfied with the quality of their sexual performance with the prescribed dose or if unwanted effects occur.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
Concomitant use of any form of organic nitrate (e.g., nitrates, nitrites, nitric oxide donors), either regularly or intermittently. A suitable time interval for administration of nitrates or nitric oxide donors following administration of vardenafil has not been determined. (See Cautions: Precautions and Contraindications, in Sildenafil 24:12.12.)
Known hypersensitivity to vardenafil or any ingredient in the formulation.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
Headache, flushing, rhinitis, dyspepsia, sinusitis, flu syndrome, dizziness, increased creatinine kinase, nausea.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
Use of vardenafil has not been evaluated and is not indicated in pediatric patients.
Category B. (See Users Guide.) Vardenafil is not indicated for use in women.
Vardenafil is excreted into milk in rats. It is not known if vardenafil is excreted into milk in humans. Vardenafil is not indicated for use in women.
An initial vardenafil dosage of 5 mg should be considered in geriatric men (65 years of age and older).
Safety and efficacy of vardenafil in geriatric men (older than 65 years of age) are similar to those in younger men. The manufacturer states that such patients should receive lower initial doses of the drug. (See Geriatric Patients under Dosage and Administration: Special Populations.)
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.